All listings for this product
Best-selling in Textbooks
Save on Textbooks
- AU $13.75Trending at AU $17.77
- AU $69.53Trending at AU $85.78
- AU $56.99Trending at AU $71.10
- AU $35.12Trending at AU $54.44
- AU $17.60Trending at AU $22.00
- AU $29.91Trending at AU $39.03
- AU $35.62Trending at AU $37.37
About this product
- DescriptionIn the late 1980s, it became painfully evident to the pharmaceutical industry that the old paradigm of drug discovery, which involved highly segmented drug - sign and development activities, would t produce an acceptable success rate in the future. Therefore, in the early 1990s a paradigm shift occurred in which drug design and development activities became more highly integrated. This new str- egy required medicinal chemists to design drug candidates with structural f- tures that optimized pharmacological (e. g. , high affinity and specificity for the target receptor), pharmaceutical (e. g. , solubility and chemical stability), bioph- maceutical (e. g. , cell membrane permeability), and metabolic/pharmacokinetic (e. g. , metabolic stability, clearance, and protein binding) properties. Successful implementation of this strategy requires a multidisciplinary team effort, incl- ing scientists from drug design (e. g. , medicinal chemists, cell biologists, en- mologists, pharmacologists) and drug development (e. g. , analytical chemists, pharmaceutical scientists, physiologists, and molecular biologists representing the disciplines of pharmaceutics, biopharmaceutics, and pharmacokinetics/drug metabolism). With this new, highly integrated approach to drug design w widely utilized by the pharmaceutical industry, the editors of this book have provided the sci- tific community with case histories to illustrate the nature of the interdisciplinary interactions necessary to successfully implement this new approach to drug d- covery. In the first chapter, Ralph Hirschmann provides a historical perspective of why this paradigm shift in drug discovery has occurred.
- PublisherSpringer Science+Business Media
- Date of Publication01/08/1998
- SubjectLife Sciences: Zoology
- Series TitlePharmaceutical Biotechnology
- Series Part/Volume Number11
- Country of PublicationUnited States
- ImprintPlenum Publishing Co.,N.Y.
- Content Note30 black & white illustrations, 1 colour illustrations, biography
- Weight1122 g
- Width152 mm
- Height229 mm
- Spine39 mm
- Edited byPhilip L. Smith,Robert M. Freidinger,Ronald T. Borchardt,Tomi K. Sawyer
This item doesn't belong on this page.
Thanks, we'll look into this.